Trends in clinical trials for articular cartilage repair by cell therapy

about

Trends in clinical trials for articular cartilage repair by cell therapy

Item

http://www.wikidata.org/entity/Q57816005

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Trends in clinical trials for articular cartilage repair by cell therapy

@en

Trends in clinical trials for articular cartilage repair by cell therapy

@nl

type

Item

label

Trends in clinical trials for articular cartilage repair by cell therapy

@en

Trends in clinical trials for articular cartilage repair by cell therapy

@nl

prefLabel

Trends in clinical trials for articular cartilage repair by cell therapy

@en

Trends in clinical trials for articular cartilage repair by cell therapy

@nl

P1476

Trends in clinical trials for articular cartilage repair by cell therapy

@en

P2093

Akifumi Matsuyama

http://www.w3.org/2001/XMLSchema#string

Hanayuki Okura

http://www.w3.org/2001/XMLSchema#string

Takaharu Negoro

http://www.w3.org/2001/XMLSchema#string

Yuri Takagaki

http://www.w3.org/2001/XMLSchema#string

P2860

Autologous, allogeneic, induced pluripotent stem cell or a combination stem cell therapy? Where are we headed in cartilage repair and why: a concise review

Applications of Chondrocyte-Based Cartilage Engineering: An Overview

Stem cell therapies for knee cartilage repair: the current status of preclinical and clinical studies.

Responsible Translation of Stem Cell Research: An Assessment of Clinical Trial Registration and Publications.

Cartilage Regeneration in Osteoarthritic Patients by a Composite of Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cells and Hyaluronate Hydrogel: Results from a Clinical Trial for Safety and Proof-of-Concept with 7 Years of Extended Follo

Advances in the Surgical Management of Articular Cartilage Defects: Autologous Chondrocyte Implantation Techniques in the Pipeline.

An Innovative, Comprehensive Mapping and Multiscale Analysis of Registered Trials for Stem Cell-Based Regenerative Medicine.

Initial phase I safety of retrovirally transduced human chondrocytes expressing transforming growth factor-beta-1 in degenerative arthritis patients.

Pharmaceutical innovation in the 21st century: new drug approvals in the first decade, 2000-2009.

Failures, re-operations, and complications after autologous chondrocyte implantation--a systematic review.

P2888

s41536-018-0055-2

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41536-018-0055-2

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30345076

http://www.w3.org/2001/XMLSchema#string

P921

cartilage

P932

6181982

http://www.w3.org/2001/XMLSchema#string